UPMC Enterprises shared a new report, "Opportunities for Action: Ending Disparities in Women's Health Research, Funding, and Access,"?which emerged from the insightful Women's Health @ Top of Mind that was hosted at the #CCM. This report is transformative, offering?24 actionable solutions?designed to revolutionize women's health. ?? ??Download the full report to explore all the opportunities for action and detailed summaries of the event discussions [https://lnkd.in/eNAgKP7M]. Here's a glimpse of what is covered ?? ??Research:?Addressing the lack of representation of women in clinical trials, identifying 8 opportunities for action. Key solutions include intentional trial design, better incentives for diversity, and innovative data collection methods like wearable technologies tailored for women. ??Funding:?Despite women making up 51% of the population, funding for women's health research is still disproportionately low. The report highlights 9 opportunities for action, emphasizing the economic and societal benefits of increased investment in women's health. ??Access:?Access to healthcare remains a significant barrier, especially for rural and underserved communities. 7 opportunities for action are identified, focusing on telehealth, enhanced medical education, standardized clinical guidelines, and equitable reimbursement to improve outcomes for all women. ?? Event Speakers: Richard Beigi, MD, MSc. | Carolee Lee | Anna Mamo, MS, MBA | Katie Berlacher | Alicia Chong Rodriguez | Nina Goodheart | Van-Khue Ton | Jessica J. Federer | Lori Frank | Christina K. Isacson Ph.D. | Luba Soskin | Jannine Versi | Michael Annichine | Jennifer Coppola | Alyson J. McGregor | Ellen Beckjord, PhD, MPH | Jocelyn Fitzgerald | Bob Edwards | Annmarie Lyons | Hyagriv Simhan | Ketki Karanam
Center for Connected Medicine
医院和医疗保健
Pittsburgh，PA 3,267 位关注者
Collaborating with experts to produce research and events on consumerism, digital solutions, and medical innovation.
关于我们
The Center for Connected Medicine (CCM) at UPMC is defining the future of the modern health system through programming that informs, connects, and inspires leaders and innovators in health care. Collaborating with a network of experts from across the health care ecosystem, the CCM focuses its research and events on consumer-centered solutions, digital transformation, and scientific and medical innovation.
- 网站
-
https://www.connectedmed.com
Center for Connected Medicine的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 2-10 人
- 总部
- Pittsburgh，PA
- 类型
- 非营利机构
- 创立
- 2009
- 领域
- Connected Medicine、Thought Leadership、Health Information Technology、Patient-Centered Care、Telemedicine、Interoperability、Analytics、Executive Briefing Center、Electronic Health Records/Data、Health Care、Communication、Cultural Change和Artificial Intelligence
地点
-
主要
获取路线
600 Grant Street
US，PA，Pittsburgh，15219
Center for Connected Medicine员工
动态
-
Congratulations to UPMC Enterprises on their Series B investment in Latigo Biotherapeutics, Inc.! ?? Latigo is developing oral Nav1.8 inhibitors for non-opioid pain relief.
UPMC Enterprises is thrilled to champion innovation in pain management through our investment in Latigo Biotherapeutics, Inc. This clinical-stage biotech company is advancing groundbreaking non-opioid pain treatments designed to directly address the source of pain with best-in-class potential. The Series B funding will support Latigo’s development of safer, long-term solutions for chronic pain. Learn more about Latigo: https://lnkd.in/d-Q5zUfP
-
UPMC Enterprises hit the ground running this year with three new investments in Ouro Medicines, Percipio Health, and Spark Pediatrics! Learn more about each exciting opportunity. ??
Since January, we have made new investments in three exciting companies that are working to improve health care — a remote patient monitoring and AI startup, a clinical daycare for medically complex children, and a biotech targeting immune-mediated diseases. Read more about each here. ????
-
The University of Pittsburgh's commitment to building a life sciences ecosystem is paving the way for groundbreaking advancements in health care through the establishment of Pitt BioForge and partnerships with industry leaders like ElevateBio. ???? These efforts are designed to streamline the development and delivery of next-generation cell and gene therapies, ensuring equitable access to cutting-edge treatments. How will BioForge impact our region as it nears completion? Read more in the 2023-2024 Pitt Research Annual Report here: https://lnkd.in/grpYYUgv
-
Listen to the latest episode of UPMC Enterprises’ podcast, Ventured, to learn how their unique model sets their portfolio companies up for success. Matthias Kleinz, Executive Vice President, Translational Sciences, and Hank Safferstein, CEO of Generian and senior advisor of UPMC Enterprises, sat down for an engaging conversation in episode 12, “Expanding the Pipeline.” ?? Download on the UPMC Enterprises blog: https://lnkd.in/ereV-KWv
There is no one size fits all approach to anything. So it's probably no surprise to anyone that the models in which scientific ideas emerge from academia and make their path through discovery and development to ultimately become commercially available therapeutic and clinical interventions are manifold. At UPMC Enterprises we have developed our own flavor, working very closely with our academic partners University of Pittsburgh School of Medicine and Carnegie Mellon University to turn incredible ideas into Life Changing Medicine. This week we sat down to review the progress of our portfolio, and it was a great reminder how the hard work of our investment and operations teams and the tenacity of the scientists and executives we work with adds up to move the needle in medicine. Our portfolio company BlueSphere Bio is taking the final steps to dose their first patients with a transformational TCR-T treatment for #AML, at Avista Therapeutics our partnership with Roche is going from strength to strength, and we are simultaneously working with a broad range of new investigators and entrepreneurs to advance new ideas from the lab into the clinic. If you want to learn more about how we do it and what makes UPMC Enterprises unique as a partner and investor in #LifeSciences check out this podcast. Together with my friend and colleague Hank Safferstein, the CEO of our portfolio company Generian, I will share more about how we work to make a difference in the life of #patients.
-
How are researchers at the University of Pittsburgh expanding health care access? ?? From video gaming for patient advocacy to tackling medical mistrust and rapidly implementing opioid treatment solutions, these initiatives are already impacting real patients’ health outcomes. https://lnkd.in/eRPWruDa
-
Under the leadership of Evan Facher, Vice Chancellor for Innovation and Entrepreneurship, the University of Pittsburgh is leveraging its robust research capabilities to foster early-stage life sciences companies. This initiative not only accelerates scientific breakthroughs but also drives economic growth and job creation in the region. Learn more about our partnership with Pitt and how #Pittsburgh is on track to being a pioneering #lifesciences hub. Download the full report from Pitt Research: https://lnkd.in/grpYYUgv
-
How is UPMC further innovating in the artificial intelligence space? Their latest technology solution, Ahavi, is addressing a critical need to ensure innovative solutions will be effective once deployed in a health care setting. Ahavi is a real-world data platform for researchers, scientists, and developers to validate AI solutions. Introduced at the 2025 ViVE digital health care conference, Ahavi provides de-identified real-world health care data sourced from more than 80 UPMC data sources. Learn more about the opportunities for Ahavi in the latest blog from UPMC Enterprises: https://lnkd.in/ddj7RMp3?
At UPMC Enterprises, we take a data-driven approach to selecting health care innovations that will have the biggest impact on UPMC’s patient population. That’s why we developed Ahavi, a digital solution that enables UPMC Enterprises partners to rigorously evaluate and refine AI models using real-world insights from UPMC’s patient population – all within a custom, secure, virtual environment. We are proud to share this breakthrough innovation with a wide range of a range of health care partners, including pharmaceutical and biotech companies, AI developers, academic researchers, and hospital systems. Learn more about Ahavi in our latest blog post: https://lnkd.in/dA6ye9pg
-
"Our goal is to provide personalized care that addresses the unique needs of each patient. By understanding the underlying causes of obesity, we can develop more effective treatment plans." - David Rometo MD, Clinical Associate Professor of Medicine and Clinical Director of the UPMC Center for Obesity Medicine. Read the 'The Future of Obesity Treatment: Is There Life Beyond GLP-1s?' expert panel recap below. ?? https://lnkd.in/eyMv4cPb
-
Congratulations, Dr. Rob Bart on a well-deserved acknowledgement.
I am truly honored to be recognized alongside so many leading innovators in health care. Thank you, Becker's Healthcare, for this acknowledgment. This recognition is not just a personal milestone—it highlights the outstanding efforts of 57 other hospital and health system CMIOs and CNIOs who are driving meaningful change for patients. I look forward to continuing to push the boundaries of what’s possible in health care. https://lnkd.in/ez6bfZZm